Skip to Main Content

Paper Details

Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
3
2023
IBD, IBDs, Inflammatory Bowel Diseases, Patients, TNF, TNF-, TNF-?, comorbidities, inflammation, inflammatory bowel diseases, patients, tumor necrosis factor, ulcerative colitis, ustekinumab, vedolizumab
Adult, Biological Products, Biological Therapy, Cohort Studies, Colitis, Ulcerative, Female, Humans, Male, Retrospective Studies, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor-alpha
Author NameAffiliation
Nghia H Nguyenuniversity of california san diego
Jiyu Luouniversity of california san diego
Paulina Pauluniversity of california san diego
Jihoon Kimuniversity of california san diego
Gaurav Syal
Christina HaMayo Clinic
Vivek A Rudrapatna
Sunhee Park
Nimisha K Parekh
Kai Zheng
Jenny Saukuniversity of california los angeles
Berkeley N Limketkaiuniversity of california los angeles
Phillip Fleshner
Samuel Eisensteinuniversity of california san diego
Sonia Ramamoorthyuniversity of california san diego
Sonia Ramamoorthyuniversity of california san diego
Gil Y Melmed
Parambir S DulaiNorthwestern University
Brigid S Bolanduniversity of california san diego
Brigid S Bolanduniversity of california san diego
Uma Mahadevan
William J Sandbornuniversity of california san diego
Lucila Ohno-Machadouniversity of california san diego
Lucila Ohno-Machadouniversity of california san diego
Dermot P B McGovern
Dermot P B McGovern
Siddharth Singhuniversity of california san diego
  • 1 - 27

Datasets

Release 1.2